Algernon Pharmaceuticals (XTER:BTI) Dividends per Share : €0.00 (TTM As of Feb. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Algernon Pharmaceuticals Dividends per Share?

Algernon Pharmaceuticals's dividends per share for the three months ended in Feb. 2024 was €0.00. Its dividends per share for the trailing twelve months (TTM) ended in Feb. 2024 was €0.00. Its Dividend Payout Ratio for the three months ended in Feb. 2024 was 0.00. As of today, Algernon Pharmaceuticals's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

Algernon Pharmaceuticals Dividends per Share Historical Data

The historical data trend for Algernon Pharmaceuticals's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Algernon Pharmaceuticals Dividends per Share Chart

Algernon Pharmaceuticals Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Dividends per Share

Get a 7-Day Free Trial

Algernon Pharmaceuticals Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Algernon Pharmaceuticals's Dividends per Share

For the Biotechnology subindustry, Algernon Pharmaceuticals's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Algernon Pharmaceuticals's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Algernon Pharmaceuticals's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Algernon Pharmaceuticals's Dividend Yield % falls into.

Algernon Pharmaceuticals Dividends per Share Calculation

Dividends paid to per common share.

Algernon Pharmaceuticals (XTER:BTI) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Algernon Pharmaceuticals's Dividend Payout Ratio for the quarter that ended in Feb. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Feb. 2024 )	/	EPS without NRI (Q: Feb. 2024 )
	=	0	/	-0.034
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Algernon Pharmaceuticals Dividends per Share Related Terms

Thank you for viewing the detailed overview of Algernon Pharmaceuticals's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Algernon Pharmaceuticals (XTER:BTI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Algernon Pharmaceuticals Inc (XTER:BTI) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

AGNPF:USA AGW0:Germany AGN:Canada

Address

601 West Broadway, Suite 400, Vancouver, BC, CAN, V5Z 4C2

Website

https://www.algernonpharmaceuticals.com

Algernon Pharmaceuticals Inc is a clinical-stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis and chronic cough. The company's business model is capital efficient and strives to deliver maximum shareholder value. Algernon's approach to drug discovery is based on the concept of drug repurposing. It operates in two reportable segments: the development of repurposed therapeutic drugs in Canada, and the facilitation of the Company's drug candidates into off-label phase II clinical trials (humans) in Australia.